Want to join the conversation?
$BCR's 3Q15 Urology sales climbed 1% YoverY to $212.3MM. Sales from the U.S. increased 5%, while improving 4% internationally. Within Urology, temperature management products grew at a double-digit rate with basic drainage business increasing 6% globally and 7% in the U.S. Further, I.C. Foley's sales were up 3% globally and 1% in the U.S.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.